# China NMPA Inspection - Ruichang Ruimei Cosmetics Co., Ltd. - August 14, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/ruichang-ruimei-cosmetics-co-ltd/01b184c3-bf4c-4ebc-918d-15fd63f87433/
Source feed: China

> China NMPA unannounced inspection for Ruichang Ruimei Cosmetics Co., Ltd. published August 14, 2019. In June 2019, regulatory authorities conducted unannounced inspections of eight cosmetic manufacturers to ensure product quality and safety, reinforci

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement from Jiangxi Provincial Drug Administration Regarding the Supervision and Inspection of Cosmetic Manufacturers (First Issue of 2019)
- Company Name: Ruichang Ruimei Cosmetics Co., Ltd.
- Publication Date: 2019-08-14
- Product Type: Cosmetics
- Summary: In June 2019, regulatory authorities conducted unannounced inspections of eight cosmetic manufacturers to ensure product quality and safety, reinforcing enterprises' primary responsibilities. The inspections revealed widespread deficiencies across all companies, highlighting significant compliance issues within the sector.Companies inspected included Ruichang Ruimei, Jiangxi Qicao, Jiangxi Novartis, Jiangxi Zhenshiming, Jiangxi Ruijian, Jiangxi Fubao, Ganzhou Aolier, and Jiangxi Laihe. Violations consistently involved multiple serious and general defects. For instance, Ruichang Ruimei had 4 serious and 5 general defects, while Jiangxi Ruijian faced 9 serious and 5 general deficiencies, ultimately failing to meet regulatory requirements. Jiangxi Laihe also failed to meet requirements with 5 serious and 4 general defects.Under the framework governing cosmetic production and licensing, various enforcement actions were mandated. Most companies, including Ruichang Ruimei, Jiangxi Qicao, Jiangxi Zhenshiming, Jiangxi Fubao, and Ganzhou Aolier, were required to rectify all identified deficiencies and report their rectification status within 30 days. Jiangxi Fubao also needed to correct non-special-use cosmetic registration materials. More severe actions were taken against others: Jiangxi Novartis had already ceased production, Jiangxi Ruijian’s Cosmetic Production License was cancelled due to significant non-compliance, and Jiangxi Laihe was ordered to suspend production until comprehensive rectification was verified and confirmed by the bureau. These actions underscore a commitment to maintaining stringent quality and safety standards in cosmetic manufacturing.

Company: https://www.globalkeysolutions.net/companies/ruichang-ruimei-cosmetics-co-ltd/8e39371b-b8f7-41e6-bbf0-7541df03ba1f/